SCHEMBL6235512

SCHEMBL6235512

CCN1CCCC1CN(CCc1ccc(OC)c(F)c1)c1nc(N)nc(NC2CCCCCC2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
PDE5A O76074 3/20 0.40
DRD2 P14416 6/20 0.39
SIGMAR1 Q99720 1/20 0.38
RECQL P46063 1/20 0.34
ALDH1A1 P00352 2/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
BCL6 P41182 1/20 0.33
MAPK1 P28482 1/20 0.33
DRD4 P21917 3/20 0.33
TSHR P16473 2/20 0.33
CA2 P00918 2/20 0.33
DRD1 P21728 2/20 0.33
DRD3 P35462 2/20 0.33
CA9 Q16790 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 2/20 0.33
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6016946 0.85 SMN1; SMN2 (0.44) SMN1; SMN2PDE5ADRD2ALDH1A1BCL6
SCHEMBL6238830 0.83 SMN1; SMN2 (0.43) SMN1; SMN2PDE5ADRD2SIGMAR1ALDH1A1
SCHEMBL5553491 0.80 GALR1 (0.46) DRD2
SCHEMBL5549889 0.78 GALR1 (0.45) SMN1; SMN2ALDH1A1MAPK1CYP2D6MAPT
SCHEMBL4832202 0.77 DRD2 (0.46) PDE5ADRD2SIGMAR1CRHBPCRHR2
SCHEMBL6229931 0.77 GALR1 (0.42) SMN1; SMN2ALDH1A1CYP2D6KDM4EHSD17B10
SCHEMBL4836400 0.76 PDE5A (0.46) SMN1; SMN2PDE5ADRD2RECQL
SCHEMBL5550316 0.75 GALR1 (0.43) SMN1; SMN2DRD2ALDH1A1CYP2D6CYP2C19
SCHEMBL6608904 0.75 GALR1 (0.43) SMN1; SMN2DRD2ALDH1A1CYP2D6CYP2C19
SCHEMBL6235105 0.75 SMN1; SMN2 (0.34) SMN1; SMN2PDE5ADRD2DRD4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1560817-A1 METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS Reddy US Therapeutics, Inc. (US) 2005-08-10 EP claimed
WO-2004026844-A1 METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS REDDY US THERAPEUTICS, INC. (US) 2004-04-01 WO claimed